BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27920668)

  • 1. Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review.
    Wen MM
    Front Mol Neurosci; 2016; 9():129. PubMed ID: 27920668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.
    Redenšek Trampuž S; Vogrinc D; Goričar K; Dolžan V
    Front Mol Neurosci; 2023; 16():1123955. PubMed ID: 37008787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics.
    Roy B; Lee E; Li T; Rampersaud M
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegenerative Disorders Treatment: The MicroRNA Role.
    Ridolfi B; Abdel-Haq H
    Curr Gene Ther; 2017; 17(5):327-363. PubMed ID: 29357791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease.
    Alkhazaali-Ali Z; Sahab-Negah S; Boroumand AR; Tavakol-Afshari J
    Biomed Pharmacother; 2024 Jun; 177():116899. PubMed ID: 38889636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.
    Karnati HK; Panigrahi MK; Gutti RK; Greig NH; Tamargo IA
    J Alzheimers Dis; 2015; 48(3):563-80. PubMed ID: 26402105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.
    Nguyen TPN; Kumar M; Fedele E; Bonanno G; Bonifacino T
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.
    Tan L; Yu JT; Tan L
    Mol Neurobiol; 2015; 51(3):1249-62. PubMed ID: 24973986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
    Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
    Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Expression of Plasma Exo-miRNA in Neurodegenerative Diseases by Next-Generation Sequencing.
    Nie C; Sun Y; Zhen H; Guo M; Ye J; Liu Z; Yang Y; Zhang X
    Front Neurosci; 2020; 14():438. PubMed ID: 32457573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients.
    Caggiu E; Paulus K; Mameli G; Arru G; Sechi GP; Sechi LA
    eNeurologicalSci; 2018 Dec; 13():1-4. PubMed ID: 30255159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal dark matter: the emerging role of microRNAs in neurodegeneration.
    Goodall EF; Heath PR; Bandmann O; Kirby J; Shaw PJ
    Front Cell Neurosci; 2013 Oct; 7():178. PubMed ID: 24133413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases.
    Wu YY; Kuo HC
    J Biomed Sci; 2020 Apr; 27(1):49. PubMed ID: 32264890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Astrocytes and microRNA Dysregulation in Neurodegenerative Diseases: From Pathogenesis to Therapeutic Potential.
    Bai Y; Su X; Piao L; Jin Z; Jin R
    Front Mol Neurosci; 2021; 14():556215. PubMed ID: 33815055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA: Basic concepts and implications for regeneration and repair of neurodegenerative diseases.
    Saraiva C; Esteves M; Bernardino L
    Biochem Pharmacol; 2017 Oct; 141():118-131. PubMed ID: 28709951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Status of microRNA-Based Therapeutic Approaches in Neurodegenerative Disorders.
    Paul S; Bravo Vázquez LA; Pérez Uribe S; Roxana Reyes-Pérez P; Sharma A
    Cells; 2020 Jul; 9(7):. PubMed ID: 32679881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common miRNA Patterns of Alzheimer's Disease and Parkinson's Disease and Their Putative Impact on Commensal Gut Microbiota.
    Hewel C; Kaiser J; Wierczeiko A; Linke J; Reinhardt C; Endres K; Gerber S
    Front Neurosci; 2019; 13():113. PubMed ID: 30890906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNAi applications in therapy development for neurodegenerative disease.
    Maxwell MM
    Curr Pharm Des; 2009; 15(34):3977-91. PubMed ID: 19751205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.